The Power of Ideas and the people behind them: Ģý publishes 2020 Global Annual Medical Report
Ģý, the worldĢýs leading provider of products and services for people with chronic kidney failure, today announced publication of its 2020 Global Annual Medical Report. Titled ĢýThe Power of Ideas: Ingenuity, Optimism, and the Future of Global Healthcare,Ģý it advances the worldwide conversation about the continuing evolution of healthcare and underlines the role Ģý can play in transforming care for chronically ill patients.
ĢýThis yearĢýs report focuses on the ideas, ingenuity, and optimism that are transforming healthcare,Ģý said Franklin W. Maddux, MD, Global Chief Medical Officer of Ģý. ĢýWe look at ways to enhance patient choice, new frontiers in connected health, the promise of artificial intelligence, and other important topics including our global response to COVID-19. Our 2020 report also shows the remarkable diversity of people behind the ideas that are helping us evolve our healthcare systems to recognize the unique lifetime journey of each kidney disease patient.Ģý
The 2020 Global Annual Medical Report comprises 24 chapters by nearly 40 authors from across the company, representing some of ĢýĢýs best thought leadership on a wide range of topics. These also include precision medicine and genomics, cardioprotective dialysis, value-based care, and transplantation.
Some of the key chapters include:
- Building on Lessons Learned: Activating a Global Pandemic Master Plan
- The Aspirational Role of Artificial Intelligence and Advanced Analytics
- The Power of Precision: Genomics Medicine and Power of Personalization of Kidney Care
- Cardioprotective Dialysis: Improving Cardiovascular Health Through More Personalized Treatment
- Driving Sustainability and Creating Value for Patients in Global Healthcare
- Increasing Access to Transplantation: Lessons from the United States
- Clinical Performance Supports Organized Value-Based Care
- Social Care and Medical Care Become Kidney Care
The 2020 Global Annual Medical Report is published by the Global Medical Office of Ģý. The full report is now available online at:
Ģý is the world's leading provider of products and services for individuals with renal diseases of which around 3.5 million patients worldwide regularly undergo dialysis treatment. Through its network of 4,036 dialysis clinics, Ģý provides dialysis treatments for 347,683 patients around the globe. Ģý is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with the core business, the company focuses on expanding the range of related medical services in the field of Care Coordination. Ģý is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).
For more information visit the CompanyĢýs website at.
Disclaimer
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to various factors, including, but not limited to, changes in business, economic and competitive conditions, legal changes, regulatory approvals, results of clinical studies, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Ģý AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Ģý AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.
